Carasent ASA has completed its planned cross-border merger
Carasent ASA has completed its planned cross-border merger with Carasent AB. Consequently, the last day of trading and listing of the Carasent ASA shares on Oslo Børs was 4 December 2024. The shares in Carasent AB are expected to start trading on Nasdaq Stockholm on 9 December 2024.
As announced on 30 August 2024, the Carasent ASA board of directors has resolved on a cross-border merger plan to effect a planned relisting of its shares on Nasdaq Stockholm (the “Relisting”). Carasent ASA’s Extraordinary General Meeting approved the merger plan on 4 October 2024 as previously announced.
Upon completion of the merger, all Carasent shareholders had their shares in Carasent ASA exchanged one-for-one with shares in Carasent AB, and Carasent ASA is struck off from Oslo Børs. The shares in Carasent AB are expected to start trading on Nasdaq Stockholm on 9 December 2024.
For further information regarding the Relisting, please go to Carasent ASA’s website: https://carasent.com/investors/relisting-to-nasdaq-stockholm-2024/.
For further information, please contact
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493